Cargando…
A Retrospective Multicentric Study of Ewing Sarcoma Family of Tumors in Patients Older Than 50: Management and Outcome
Ewing’s sarcoma family of tumors (EFTs) is a group of rare and aggressive tumors. Data on EFTs in patients (pts) ≥ 50 years are limited and these pts are often not eligible for clinical trials. Some, but not all, studies have reported inferior outcome for older pts with EFTs. We conducted an IRB-app...
Autores principales: | Rochefort, Pauline, Italiano, Antoine, Laurence, Valérie, Penel, Nicolas, Lardy-Cleaud, Audrey, Mir, Olivier, Chevreau, Christine, Bertucci, Francois, Bompas, Emmanuelle, Chaigneau, Loic, Levy, Dominique, Ryckewaert, Thomas, Dumont, Sarah, Meeus, Pierre, Ranchere, Dominique, Blay, Jean-Yves, Cassier, Philippe Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738347/ https://www.ncbi.nlm.nih.gov/pubmed/29263409 http://dx.doi.org/10.1038/s41598-017-17733-z |
Ejemplares similares
-
Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial
por: Lebellec, Loïc, et al.
Publicado: (2018) -
Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program
por: Blay, Jean-Yves, et al.
Publicado: (2013) -
Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience
por: Levard, Alice, et al.
Publicado: (2013) -
The off-label use of targeted therapies in sarcomas: the OUTC’S program
por: Eberst, Lauriane, et al.
Publicado: (2014) -
Pazopanib for the treatment of soft-tissue sarcoma
por: Heudel, Pierre, et al.
Publicado: (2012)